Correlation Between Mydecine Innovations and HempAmericana

Can any of the company-specific risk be diversified away by investing in both Mydecine Innovations and HempAmericana at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mydecine Innovations and HempAmericana into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mydecine Innovations Group and HempAmericana, you can compare the effects of market volatilities on Mydecine Innovations and HempAmericana and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mydecine Innovations with a short position of HempAmericana. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mydecine Innovations and HempAmericana.

Diversification Opportunities for Mydecine Innovations and HempAmericana

0.08

Correlation Coefficient

Mydecine Innovations  HempAmericana

Significant diversification

The 3 months correlation between Mydecine and HempAmericana is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Mydecine Innovations Group and HempAmericana in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HempAmericana and Mydecine Innovations is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mydecine Innovations Group are associated (or correlated) with HempAmericana. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HempAmericana has no effect on the direction of Mydecine Innovations i.e., Mydecine Innovations and HempAmericana go up and down completely randomly.

Pair Corralation between Mydecine Innovations and HempAmericana

Assuming the 90 days horizon Mydecine Innovations Group is expected to generate 1.16 times more return on investment than HempAmericana. However, Mydecine Innovations is 1.16 times more volatile than HempAmericana. It trades about 0.12 of its potential returns per unit of risk. HempAmericana is currently generating about 0.06 per unit of risk. If you would invest  1.80  in Mydecine Innovations Group on October 8, 2024 and sell it today you would lose (1.40) from holding Mydecine Innovations Group or give up 77.78% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Mydecine Innovations Group  vs.  HempAmericana

Mydecine Innovations

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Mydecine Innovations Group are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Mydecine Innovations reported solid returns over the last few months and may actually be approaching a breakup point.

HempAmericana

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in HempAmericana are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, HempAmericana reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Mydecine Innovations and HempAmericana

The main advantage of trading using opposite Mydecine Innovations and HempAmericana positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mydecine Innovations position performs unexpectedly, HempAmericana can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HempAmericana will offset losses from the drop in HempAmericana's long position.

The idea behind Mydecine Innovations Group and HempAmericana pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.